Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2024-01-03 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It details the recent abnormal stock price movements, the company's investigation into possible causes, and confirms no undisclosed material information affecting stock price. It also states no insider trading occurred during the period. The document is regulatory in nature, related to stock price movement disclosures under Beijing Stock Exchange rules. It is short (1247 characters) and does not contain financial statements or detailed financial data. It is not an annual report, earnings release, or management report. It is a regulatory announcement about stock trading behavior and compliance. Therefore, it fits best under Regulatory Filings (RNS).
2024-01-03 Chinese
关于更换持续督导保荐代表人的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the replacement of the continuous supervision sponsor representative for the company. It details personnel changes related to the sponsor representatives responsible for ongoing supervision duties until a specified date. There is no financial data, no report attached or referenced as being published, and no mention of financial results or regulatory filings beyond this personnel update. This fits the category of Board/Management Information (MANG), as it concerns changes in company representatives related to governance and oversight roles.
2024-01-02 Chinese
投资者关系活动记录表
Investor Presentation Classification · 90% confidence The document is an investor relations activity record from a company, detailing a media interview with the chairman discussing business strategy, market conditions, product development, and capital market activities. It contains no financial statements or detailed financial data, nor is it a transcript of a conference call or an official report. It is a record of an investor relations event, specifically a media interview, which fits best under the category of Investor Presentation (IP) as it provides detailed information for investors about the company's strategy, market position, and outlook.
2023-12-26 Chinese
对外投资设立全资孙公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's external investment to establish a wholly-owned subsidiary in Hong Kong. It details the investment overview, approval status, investment amount, and the purpose and risks of the investment. There are no financial statements, audit information, or detailed financial performance data. The document is a formal announcement of a corporate action related to investment and subsidiary establishment, not a financial report or regulatory filing of financial results. It fits best under Capital/Financing Update (CAP) as it concerns company fundraising or capital structure changes through investment activities.
2023-11-30 Chinese
对外投资设立全资子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's external investment to establish a wholly-owned subsidiary. It details the investment amount, purpose, risk assessment, and compliance with regulatory requirements. There are no financial statements or detailed financial performance data included. The document is a formal announcement of a capital investment activity, specifically the establishment of a subsidiary, which relates to changes in the company's capital structure but does not involve new share issuance or stock splits. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is CAP with high confidence.
2023-11-30 Chinese
关于取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Sichuan Qianli Beiyikang Medical Technology Co., Ltd. regarding the acquisition of a medical device registration certificate issued by the Sichuan Provincial Drug Administration. It details the certificate specifics, the impact on the company, and a risk warning. The document is short (714 characters) and serves as an official announcement of a regulatory approval rather than a financial report or detailed filing. It does not contain financial data, management changes, or voting results. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-11-15 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.